Sevim HCT Tablet 5/40/12.5 mg

Adult dose

This medication is taken once daily, one tablet, with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). The recommended dosage is as follows: - 5/20/12.5mg: For patients whose blood pressure is not adequately controlled on a combined therapy of amlodipine/olmesartan medoxomil 5/20mg. - 5/40/12.5mg: For patients whose blood pressure is not adequately controlled on a combined therapy of amlodipine/olmesartan medoxomil 5/40mg.

Child dose

The safety and efficacy for pediatric patients under 18 years have not been established; therefore, administration of this medication is not recommended.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters. Therefore, it must be stopped immediately if pregnancy is confirmed. Patients with allergies to this medication or its ingredients, or those with certain heart, kidney, or liver diseases should not take this medication. It should not be used in cases of very low blood pressure, acute heart failure, or severely impaired kidney function. Patients with decreased blood volume may experience hypotension upon initial use, so caution is needed, and healthcare professionals will take appropriate measures if necessary. This medication can affect kidney function, so patients with kidney diseases or those who have undergone kidney transplantation should have regular blood tests. Patients with poor liver function should also use this medication with caution and it is not recommended for patients with severe liver diseases. During treatment, blood pressure may drop too low causing dizziness or a feeling of lightheadedness; thus, it is advisable to avoid driving or operating hazardous machinery. This medication can interact with other antihypertensive medications or certain drugs, so inform healthcare professionals of any medications being taken. Photosensitivity reactions may occur, so take care to protect the skin from sunlight or UV exposure, and consult a doctor if any adverse reactions occur after taking this medication. The use of this medication is not recommended during breastfeeding, and if necessary, breastfeeding should be stopped or the medication discontinued. Safety and efficacy in pediatric patients under 18 years have not been established, so it is advisable not to use it in this age group. In case of overdose, symptoms may include low blood pressure, palpitations, bradycardia, etc., and immediate medical assistance should be sought if any symptoms appear. This medication should be stored in a tightly closed container out of direct sunlight and moisture, away from children's reach.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, paleness, severe rash accompanied by high fever, blisters, peeling of the skin, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizures, altered consciousness, vision abnormalities, paralysis, decreased urine output

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be kept at room temperature between 1 and 30 degrees Celsius.

Appearance

Pale yellow round film-coated tablets

Package unit

30 tablets (10 tablets/Alu-Alu × 3)